chrisvoncsefalvay/vaers-outcomes huggingface dataset:
09/18/02 3:45pm hep A and B vaccines administered. 3:50pm client stated, "My stomach feels fuzzy." Assisted to lie down on exam table with legs elevated. Client stated "I haven't eaten since breakfast." Mom said, "That was about 11 o'clock this morning." Gave client sugar water with 1 tsp. sugar in approximately 2 oz. H2O. Client drank it. Offered lemon pound cake. Client took a couple bites. BP 102/62. 4:10pm client's father brought her a candy bar and a cola. Client ate a couple bites of the candy bar and drank a couple sips of cola. 4:15pm "I want to go to bathroom." Mother and I assisted client to ambulate into hallway. Client stated, "My vision is getting hazy." Assisted to lie down with legs elevated. 4:20pm, "My legs are going to sleep and the sides of my stomach hurt. I'm tired. " Noted  client drifting into sleep, closing eyes, staring into space. Client able to move legs, oriented to time, place and person, able to follow simple commands. BP 98/62 resp 12. Oxygen started via blow-by method at 6 liters per minute. 4:25pm called 911, activated EMS "I'm tired, I want to sleep. My legs are asleep." Continued oxygen and instructing client to breathe in through nose, out through mouth. 4:30pm "It feels like I can't breathe." Respirations 10. 4:35pm administered epinephrine 1/1000 0.3cc right deltoid IM. BP 160/110 immediately afterwards. Pulse 60, repirations 16. "My chest hurts." Noted rapid breathing with full chest expansion, heart rate strong, pounding with sinus arrhythmia per ausculation. Still lying down and able to follow commands, oriented to time, place, person. Oxygen continued at 6 liters per minute per blow-by. 4:40pm EMS arrived. BP 150/80, pulse 100. 4:45pm temp 97.4 degrees F orally. EMT switched pt from blow-by oxygen to oxygen via nasal cannula. 4:50pm completed report to EMS. 4:55pm transported to medical center via ambulance.
Patient reports discomfort night of vaccine but nothing else that night. Over next several days began to experience Nausea, Diarrhea, aches, swollen arm, redness, and severe pain that has dulled since then.
At 1100, patient reported dizziness, drop in blood pressure, and feeling hot to EMT. Patient assisted to anti-gravity chair and given water. Patient denied pain, itchiness, rashes and hives. EMT assessed patient vitals: blood pressure 82/42 mmHg, heart rate 83 beats/minute and 98% SpO2. Patient advised to wait for further observation. Patient reassessed at 1130. Patient's vitals were blood pressure 116/72 mmHg, heart rate 95 beats/minute, and SpO2 98%. Patient reported she felt better. EMT educated patient on communicating with her vaccinator for her second dose how she reacted to her first dose. At 1105, patient left facility to self with steady gait and unlabored respirations.
This is a spontaneous report from a contactable vaccine manager and from a contactable office manager reporting on behalf of a physician. A male patient of an unspecified age and ethnicity received PREVNAR 13 via an unspecified route of administration on 01Aug2016 at single dose. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced Guillain Barre syndrome on an unspecified date in 2016. The event required hospitalization since an unknown date in 2016. Event outcome was unknown at the time of report.
Had received PNEUMOVAX 23 1/26/10 at about 11:00 AM. By 2:15 P on same day, reported L deltoid pain. Entire area appeared sl. swollen and sl. red. No systemic symptoms. Ice applied. Instructed on symptoms to watch for. On 1/27/10 reported nausea, H/A, and feverish feeling about midnight. Increased redness and swelling from shoulder to 1" above elbow. No SOB or further systemic symptoms. Dr. to examine. 1/27/10 120/84, 80, 20, 98.2.
Expired vaccine used; Error resulting in administration of expired Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Error resulting in administration of expired Vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Error resulting in administration of expired Vaccine). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Error resulting in administration of expired Vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product information was provided. No treatment information was provided.
rt arm swollen, breast swollen, red rings around rt arm almost down in armpit;had a h/a 14OCT98;sick to stomach;pt called clinic no one there;
No additional AE details were provided and no additional AE's were reported; a dose of VARIVAX was administered intramuscularly instead of subcutaneously; This spontaneous report was received from a nurse referring to a patient of unknown gender and age. Information of the patient's pertinent medical history, concomitant therapy, concurrent condition and drug reactions/allergies were not reported.  On 19-DEC-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (0.5 milliliter, lot # U016065, expiration date reported in system, so no need to upon internal review and established as 20-MAY-2023, strength and frequency were not reported) intramuscularly instead of subcutaneously for prophylaxis (incorrect route of product administration). No additional AE details were provided and no additional adverse event (AE) were reported (no adverse event).
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. On an unknown date in 2014, PROQUAD (Merck) underwent a temperature excursion. On 26-AUG-2014, the patient was vaccinated with PROQUAD (Merck) 0.5 ml, subcutaneous. No adverse effect reported. This is one of several reports report form the same source. Additional information has been requested.
Compliant of dizziness. Patient is insulin dependent diabetic. AM Blood sugar 140. Had 60 units of NPH in the morning. Felt better after drinking some juice.  Discharged home after 15 minutes observation.
On 6/14/2010 pt presented with shingle-like rash on left abdomen. The rash with blisters has remained on left abdomen x 3 days. Pt was treated by his PCP with VALTREX. He denies pain also with rash.
5 years old was given the booster dose of the Moderna COVID 19 vaccine (0.25 mL); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (5 years old was given the booster dose of the Moderna COVID 19 vaccine (0.25 mL)) in a 5-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 31-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (5 years old was given the booster dose of the Moderna COVID 19 vaccine (0.25 mL)). On 31-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (5 years old was given the booster dose of the Moderna COVID 19 vaccine (0.25 mL)) had resolved.            Concomitant medications was not provided by the reporter. Treatment information was not provided.
Pt had a positive COVID test on 2/18/22 at the hospital (Medical Center) and was dc'd on 2/19/22 without qualifying for any COVID treatments; 3/4/22 pt brought to ED and admitted to hospital with AMS; initial CT of head  showed no abnormal findings; pt did have a UTI; A Fib with RVR - started on heparin drip; later CT of head showed subdural hematoma - surgery not recommended; family decided on comfort care measures and pt expired in the hospital
I am orthopaedic spine surgeon and I started having bilateral groin pain around 11 am on 12/29/20 after performing a lumbar spine surgery.  Both of my lymph nodes in my groin were swollen and tender to palpation. I took 800mg of motrin at 12 noon. I went home at 4 pam and felt tire. I started having chills around 6 pm and this lasted for 5 hours together with body aches especially in my knees and ankles. I was shivering a lot. I took 24 mg of prednisone, 800mg motrin, vitamin c and hydroxychloroquine together with some herbs (neonox/tumeric/ginger). My highest temperature was 99.7. Around midnight, I became extremely hungry and my wife made me a bowl of chicken broth soup. I drank it and started sweating profusely and my fever broke.. My body ache has resolved but I still have some tenderness in both lymph nodes (groin).
PATIENT CAME IN DAY AFTER RECEIVING FLUZONE HD VACCINE AND SHOWED PHARMACIST ON DUTY (MYSELF) HER ARM STATING THAT IT IS INFECTED.    SHE RECEIVED THE VACCINE AT NOON AND BY 3 PM IT WAS ITCHY, SWOLLEN AND RED.  THE AFFECTED AREA STARTS ABOUT 1 INCH BELOW WHERE VACCINE WAS INJECTED AND GOES TO ABOUT THE MIDDLE OF THE ARM.  SHE WENT TO CLINIC AT 9:30 AM ON10/15/2022.  SHE WAS PRESCRIBED CEPHALEXIN WHICH WAS BEING PICKED UP AT A DIFFERENT PHARMACY.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-689916 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Followup received wherein the patient age group and narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-689916:
Narrative:  Pt reported nausea/vomiting happened in the past from influenza vaccine. Md flagged pt's chart with ADR to it. This reaction was preciously on pt's chart from 2/27/2006 but had not been reported to VAERS. Entered as a "historical" report since was not observed by staff.
PHARYNGITIS. Information has been received on 05-MAR-2003 from a nurse practitioner concerning an 18 to 20 year old male in the recent past was vaccinated with hepatitis B vaccine recombinant (yeast) (1.0ml)(IM). The patient subsequently developed pharyngitis. The patient sought unspecified medical attention.
01/04 After experiencing this "lump" in my throat for a few days I decided to contact my PCP and was set up a meeting where I was checked for Covid at the door on 01/05. After a couple of days, was informed I had Covid and was order quarantined for 5 days and had to wear a mask after. Was informed to keep a hot compress on lump and if got worse to call back. Also, advised not to get a mammogram.
This spontaneous report as received from a healthcare worker refers to a 1 year old patient of unknown gender. Concomitant medication and pertinent medical history were not provided. On 29-JUL-2014 the patient was vaccinated with an expired dose of M-M-R II (rHA) (injection, batch # J008882, lot# 0293AA, expiration date 27-JUL-2014, dose, route and frequency were not provided). No adverse effect has been observed or reported. Additional information has been requested.
No Additional AEs or PQC reported.; expired dose of RECOMBIVAX administered to a patient; Information has been received from a nurse, referring to a 4 month old patient of unknown gender. Information of concurrent condition, medical history and concomitant therapy was not provided.      On 02-NOV-2021, the patient was vaccinated with expired dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (thimerosal-free) (strength unknown; lot# S022584 and expiration date 31-OCT-2021) 0.5 milliliter intramuscularly for prophylaxis (expired product administered).  No Additional no adverse event.
Fever, body aches, chills, swelling of arm and redness that was spreading.
Swelling of upper arm with extensive redness (about 5") from shoulder to mid arm, tender to touch
Arm is a little itchy; Arm was quite sore; Had no energy at all; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm is a little itchy), PAIN IN EXTREMITY (Arm was quite sore) and ASTHENIA (Had no energy at all) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot (Patient received the regular flu shot two weeks ago) in October 2021. Past adverse reactions to the above products included No adverse event with Flu shot.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Oct-2021, the patient experienced PRURITUS (Arm is a little itchy) and PAIN IN EXTREMITY (Arm was quite sore). 24-Oct-2021, the patient experienced ASTHENIA (Had no energy at all). On 29-Oct-2021, ASTHENIA (Had no energy at all) had resolved. At the time of the report, PRURITUS (Arm is a little itchy) and PAIN IN EXTREMITY (Arm was quite sore) outcome was unknown.            No concomitant medications reported by reporter No treatment medications provided by the reporter.   This case was linked to MOD-2021-368995, MOD-2021-369007 (Patient Link).
pt states that on 2/2/2021 his left arm was itchy and tender.  Later that day the arm was itching, red and the skin was hot and a little swollen around the injection site.
patient under 18 years got a dose of the Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years got a dose of the Moderna vaccine) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 28-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years got a dose of the Moderna vaccine). On 28-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years got a dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-336648 (Patient Link).
faint; has an adverse reaction to Moderna/happened again this afternoon, and didn't go away for like the same time 20 to 30 minutes.; started falling very dizzy/happened again this afternoon, and didn't go away for like the same time 20 to 30 minutes.; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (faint) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced SYNCOPE (faint) (seriousness criterion medically significant), VACCINATION COMPLICATION (has an adverse reaction to Moderna/happened again this afternoon, and didn't go away for like the same time 20 to 30 minutes.) and DIZZINESS (started falling very dizzy/happened again this afternoon, and didn't go away for like the same time 20 to 30 minutes.). At the time of the report, SYNCOPE (faint), VACCINATION COMPLICATION (has an adverse reaction to Moderna/happened again this afternoon, and didn't go away for like the same time 20 to 30 minutes.) and DIZZINESS (started falling very dizzy/happened again this afternoon, and didn't go away for like the same time 20 to 30 minutes.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.  Patient stated that she has an adverse reaction to Moderna, she received it yesterday and started falling very dizzy and faint, that lasted about 20- 30 minutes and went away, and today patient woke up felling Okay and it wasn't, and happened again this afternoon, and didn't go away for like the same time 20 to 30 minutes.  Company Comment This case concerns a female patient of an unknown age with no reported medical history, who experienced the serious expected event of Syncope. The event occurred the same day after an unspecified dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA -1273 vaccine is not affected by this report.; Sender's Comments: This case concerns a female patient of an unknown age with no reported medical history, who experienced the serious expected event of Syncope. The event occurred the same day after an unspecified dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA -1273 vaccine is not affected by this report.
Patient in hospital Admitted to hospital and tested positive on 7/29/2021 Received Pfizer COVID vaccine on 1/7/2021 & 1/27/2021
Headache, Myalgia, Fever, Injection site discomfort Narrative:
Patient's blood pressure raised to 150s over 80s beginning the day after the vaccine and continuing for 3 days.
Patient states that she developed swelling and tenderness in the left side of the neck the day after the vaccine (6/4/21). Swelling is located on the same side that she received her vaccine. Swelling has been present since 6/4/21 and has not decreased or improved.
Developed subjective fever, nausea, myalgia and diarrhea starting 1d after 2nd vaccine. On day 14 after vaccine after systemic symptoms gone he developed pain, paresthesia and weakness in left arm.  Exam consistent with C5 and C6 radiculopathy (motor and sensory impaired); managed symptomatically; MRI C-spine with 1.5 long x 0.5cm wide column of  segmental demyelination at C4-C5 similar to lesions in neuromyelitis optica.
Patient is a 60-year-old male with a past medical history significant for multiple sclerosis with quadriparesis, diffuse alveolar hemorrhage status post tracheostomy and PEG placement, hypertension who presents to our facility today for shortness of breath. Per patient's wife, patient developed increasing secretions as well as a headache and an episode of emesis last night. She further had a temperature of 102°F this morning and tested positive for Covid at his ECF. Patient is vaccinated ×2 with Pfizer. Patient's wife states that patient's tracheostomy was capped 2 weeks ago and that patient has been doing well on room air until today. ROS limited as patient intermittently shakes his head in response to questions.
hurt all over; numbness in shot arm; headache; nauseous; shortness of breath that was scary; pouring sweat/excessive sweating; itching; eye twitching; sick; really tired; This is a spontaneous report from a contactable consumer or non-health care professional (patient). A 55-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine) (Lot/batch number: unknown) dose number 1 via unspecified route of administration on left arm as a single dose on 13Mar2021 at 12:00 (at the age of 55-year-old) for COVID-19 immunization. Patient was non-pregnant at the time of vaccination. Medical history included high blood pressure (BP) and fibromyalgia. No history of allergy to any medication or food or other products. Concomitant medications included the patient received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no symptoms associated with COVID-19. Patient had not tested positive for COVID-19 since having the vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 14Mar2021, patient experienced scary shortness of breath, hurting all over, eye twitching, headache, excessive sweating/pouring sweat, numbness in shot arm, itching, really really tired, nauseous and was feeling sick for consecutive three days after vaccination. There was no treatment received for the adverse event. The clinical outcome of all the events was recovered with sequelae on an unspecified date in Mar2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 9/4/12 Tdap was given in (L) deltoid. One day later some swelling, redness, itching noted. 2 days later (9-6-12) came back to office with increased edema, erythema, warmth, bruising, small blister at site of injection increased pruritus. Pt received Hep A and Mening in (R) deltoid the same day.
This is a serious spontaneous case, initially received on 01-Nov-2017, from a nurse, concerning a female pregnant patient of unspecified age. On an unspecified date in 2016 (as reported, last year), the pregnant patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, frequency: once (as reported), batch number, expiry date: not reported). On an unspecified date (reported as in past), after vaccination, the patient had miscarriage. It was reported that the patient was pregnant again and was in first trimester. She did not receive flu vaccine yet and plans to delay the vaccination a little longer until the first trimester. Follow-up received from other health professional (nurse) on 01-Feb-2018: Follow-up for this case is not being sought as consumer refuses to be contacted for any further information. No changes were made in the narrative, as no additional information received.
In the past I have had subconjunctival hemorrhage three times, but years apart.  I have had three since my Covid vaccine.  One each in April, June, and July.